Activation of recombinant human protein C

By Lee T.K.   Bangalore N.   Drohan W.N.   Lubon H.   Velander W.  

Thrombosis Research, Vol. 82, Iss. 3, 1996-05 ,pp. : 225-234

Elsevier

Access to resources Recommend Favorite

Species specificity of anticoagulant activity of activated human protein C. Involvement of factor V as well as protein S

By Katsuura Y.   Mochizuki T.   Tamura M.   Hoshide S.   Kiyoki M.   Nakagaki T.   Miyamoto S.  

Thrombosis Research, Vol. 82, Iss. 2, 1996-04 ,pp. : 147-157

Elsevier

Access to resources Recommend Favorite

Full-length human tissue factor pathway inhibitor inhibits human activated protein C in the presence of heparin

By Hamamoto T.   Kisiel W.  

Thrombosis Research, Vol. 80, Iss. 4, 1995-11 ,pp. : 291-297

Elsevier

Access to resources Recommend Favorite

Clinical and laboratory effects of recombinant human activated protein C in the treatment of a patient with sepsis-induced multiple organ failure

By Brueckmann M.   Wizenmann J.   Hoffmann U.   Seeger M.   Bewig B.  

Thrombosis Research, Vol. 109, Iss. 5, 2003-03 ,pp. : 259-263

Elsevier

Access to resources Recommend Favorite

Activated Protein C Induction of MCP-1 in Human Endothelial Cells - A Possible Role for Endothelial Cell Nitric Oxide Synthase

By Hooper W.C.   Phillips D.J.   Renshaw M.A.  

Thrombosis Research, Vol. 103, Iss. 3, 2001-08 ,pp. : 209-219

Elsevier

Access to resources Recommend Favorite